In the pooled analysis of all studies evaluating pancreatitis incidence (Figure 2), GLP‐1 RA use was associated with a statistically significant increase in risk (RR = 1.44; 95% CI: 1.09–1.89; p = 0.009; I2 = 0%). This evidence concerns the gene GLP1R and pancreatitis.